CD274 and non-small cell lung carcinoma: Research indicates that overweight and obese NSCLC patients undergoing ICIs exhibit better progression-free survival (PFS) and OS than their non-obese counterparts, with a more pronounced trend in patients expressing positive programmed cell death ligand-1 (PD-L1) (6).